ClotCare: Blood Clots, Stroke, Heart Attack
Thursday, September 21, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

New Data on TIAs and Stroke Prevention

Susan C. Fagan, Pharm.D., BCPS, FCCP
April 2004

Review: Eliasziw M et al. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004; 170(7):1105-1109.

Patients who experience a transient ischemic attack (TIA), sometimes called a "mini stroke", and return to normal neurologic function within 24 hours, are often relieved that they have "dodged the bullet" associated with a major stroke. Despite its seemingly benign course, a TIA is a serious medical condition that requires prompt attention and intervention.

In this subgroup analysis from the North American Symptomatic Carotid Endarterectomy Trial (NASCET), 603 patients with a hemispheric TIA and internal carotid artery stenosis >50% were randomized to the medical arm (no surgery, just aspirin, usually). In this group, the 90-day risk of ipsilateral stroke was very high (20.1%) and much higher than a similar-sized group of patients with stroke at entry into the trial (2.3%). The highest risk was in the 48 hours after the TIA (5.5%), proving that there is urgency in the need for interventions that decrease stroke risk. Patients with TIA symptoms should seek immediate medical attention so that the cause can be found (perhaps carotid artery disease) and secondary prevention strategies can be initiated.

Read the article on the Canadian Medical Association Journal website at http://www.cmaj.ca/cgi/content/full/170/7/1105


Review: O'Rourke F et al. Current and future concepts in stroke prevention. CMAJ 2004; 170(7):1123-1133.

This article is an excellent review of the current thinking regarding prevention of stroke in patients at risk. It is particularly useful in that all of the large clinical trials that are pivotal in our understanding of the approach to stroke prevention are presented in tabular form. The authors recommend antiplatelet agents for secondary prevention of ischemic stroke except when the patient has atrial fibrillation or recent MI, where anticoagulation with warfarin is recommended. In addition, the authors present data to support blood pressure lowering (with ACE inhibitors and diuretics) and statins for secondary stroke prevention. For patients with symptomatic carotid artery disease, the importance of carotid endarterectomy is stressed although, for asymptomatic disease, aggressive medical therapy is advocated.

Read the article on the Canadian Medical Association Journal website at http://www.cmaj.ca/cgi/content/full/170/7/1123


Review: Johnston DCC, Hill MD. The patient with transient cerebral ischemia. CMAJ 2004; 170(7):1134-1137.

This article is an instructional case where a patient with a 30 minute episode of focal neurologic symptoms is evaluated to determine the best strategies for secondary stroke prevention. He has a history of hypertension and dyslipidemia. The essentials of the diagnosis, including imaging are discussed in depth. A case for clinical trials to study early intervention after TIA is made. This short paper demonstrates how to apply the content of papers #1 and #2 (above) in clinical practice.

Read the article on the Canadian Medical Association Journal website at http://www.cmaj.ca/cgi/content/full/170/7/1134

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?

Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Thursday, September 21, 2017